Sydnexis Receives FDA Acceptance for SYD-101 New Drug Application for Pediatric Myopia
The low-dose atropine formulation could be the first approved drug in the United States to slow myopia in children. On…
The low-dose atropine formulation could be the first approved drug in the United States to slow myopia in children. On…
![[TFG]_Eyelid_Margin_Health_Series_ep__3__Eyelid_Margin_Health_Series__3_Diagnostic Based_Decision_Tree_for_Demodex_Blepharitis_&_MGD_Treatment](https://cookiemagazine.org/wp-content/uploads/sites/6/2025/04/TFG_Eyelid_Margin_Health_Series_ep__3__Eyelid_Margin_Health_Series__3_Diagnostic-Based_Decision_Tree_for_Demodex_Blepharitis__MGD_Treatment-579x326.png)
![[TFG] Masterclass ep _6 thumbnail WSPOS Myopia Management Masterclass Essential Follow Up](https://cookiemagazine.org/wp-content/uploads/sites/6/2025/02/TFG-Masterclass-ep-_6-thumbnail-WSPOS-Myopia-Management-Masterclass-Essential-Follow-Up-579x326.png)
![[Topcon Healthcare] KOL Interview Woon Pak Seong thumbnail_IMG](https://cookiemagazine.org/wp-content/uploads/sites/6/2025/02/Topcon-Healthcare-KOL-Interview-Woon-Pak-Seong-thumbnail_IMG-579x326.png)
